Georgetown Univ Sch of Med
Welcome,         Profile    Billing    Logout  
 3 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kumar, Princy
EMBRACE, NCT05996471: A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV)

Active, not recruiting
2
135
US
VH3810109, Cabotegravir, Standard of care (SOC), rHuPH20
ViiV Healthcare
HIV Infections
11/24
01/29
CALYPSO, NCT04401436: COVID-19 Associated Lymphopenia Pathogenesis Study in Blood

Completed
N/A
240
US
National Institute of Allergy and Infectious Diseases (NIAID)
Coronavirus Disease 2019
02/25
02/25
NCT04998019: PositiveLinks: mHealth for DC Cohort

Recruiting
N/A
753
US
PositiveLinks
George Washington University, National Institute of Mental Health (NIMH), University of Virginia
HIV/AIDS
04/25
06/25
PROMISE-US, NCT05388474: A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab

Recruiting
N/A
200
US
No ibalizumab or Pre-ibalizumab treatment, Ibalizumab, On ibalizumab treatment
Theratechnologies, Excelsus Statistics Inc., Health Psychology Research Group (HPR), ICON Clinical Research
HIV Infections, Multi-Antiviral Resistance
12/25
06/26
DC Cohort, NCT01206920: Development of a City-Wide Cohort of HIV-Infected Persons in Care in the District of Columbia: the

Recruiting
N/A
15000
US
George Washington University, National Institute of Allergy and Infectious Diseases (NIAID)
HIV, AIDS
01/41
01/41
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kumar, Princy
EMBRACE, NCT05996471: A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV)

Active, not recruiting
2
135
US
VH3810109, Cabotegravir, Standard of care (SOC), rHuPH20
ViiV Healthcare
HIV Infections
11/24
01/29
CALYPSO, NCT04401436: COVID-19 Associated Lymphopenia Pathogenesis Study in Blood

Completed
N/A
240
US
National Institute of Allergy and Infectious Diseases (NIAID)
Coronavirus Disease 2019
02/25
02/25
NCT04998019: PositiveLinks: mHealth for DC Cohort

Recruiting
N/A
753
US
PositiveLinks
George Washington University, National Institute of Mental Health (NIMH), University of Virginia
HIV/AIDS
04/25
06/25
PROMISE-US, NCT05388474: A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab

Recruiting
N/A
200
US
No ibalizumab or Pre-ibalizumab treatment, Ibalizumab, On ibalizumab treatment
Theratechnologies, Excelsus Statistics Inc., Health Psychology Research Group (HPR), ICON Clinical Research
HIV Infections, Multi-Antiviral Resistance
12/25
06/26
DC Cohort, NCT01206920: Development of a City-Wide Cohort of HIV-Infected Persons in Care in the District of Columbia: the

Recruiting
N/A
15000
US
George Washington University, National Institute of Allergy and Infectious Diseases (NIAID)
HIV, AIDS
01/41
01/41

Download Options